Literature DB >> 16850521

The effect of shock wave lithotripsy on nitric oxide and malondialdehyde levels in plasma and urine samples.

Hülya Aksoy1, Yilmaz Aksoy, Hamdullah Turhan, Sait Keleş, Tevfik Ziypak, Isa Ozbey.   

Abstract

Shock wave lithotripsy (SWL) is accepted as the first treatment choice for most urinary stones, but it has adverse effects on the kidneys. The mechanisms underlying shock wave-induced renal injury have been discussed and include shear stress, thermal and cavitation effects and free radical formation. We investigated the effects of SWL on plasma and urinary nitrite, a stable metabolite of nitric oxide (NO), and malondialdehyde (MDA) concentrations. Between February and October 2004, 12 men and 8 women with renal calculi were treated using a Dornier MPL-9000 lithotriptor. The ages ranged from 22 to 45 years (average age: 33.7 years). Plasma and urinary NO and MDA levels were analysed before, immediately after, 30 and 60 min and 24 h after SWL. Plasma NO levels were higher than baseline levels immediately, and at 30, 60 min and 24 h after treatment (p = 0.016, p = 0.031, p = 0.033 and p = 0.045, respectively). Simultaneously, the mean urinary NO levels also showed significant elevation after SWL compared with baseline values, except for 24 h (p = 0.021, p = 0.023 and p = 0.048, respectively). The mean levels of plasma MDA showed statistically significant elevation immediately, and 30 and 60 min after SWL termination compared with pre-SWL values (p = 0.012, p = 0.008 and p = 0.012, respectively). Urinary MDA levels obtained immediately (p = 0.035), and 30 (p = 0.006) and 60 (p = 0.045) min after SWL were increased compared to pre-SWL values. We speculate that SWL treatment causes oxidative stress caused by renal ischemia-reperfusion (I/R) injury. Additionally, the increase of NO production may have prevented renal damage caused by vasoconstriction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16850521     DOI: 10.1002/cbf.1349

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  8 in total

1.  Impact of official technical training for urologists on the efficacy of shock wave lithotripsy.

Authors:  Atsushi Okada; Takahiro Yasui; Kazumi Taguchi; Kazuhiro Niimi; Yasuhiko Hirose; Shuzo Hamamoto; Ryosuke Ando; Yasue Kubota; Yukihiro Umemoto; Keiichi Tozawa; Shoichi Sasaki; Yutaro Hayashi; Kenjiro Kohri
Journal:  Urolithiasis       Date:  2013-07-03       Impact factor: 3.436

2.  The protective effects of the traditional Chinese herbs against renal damage induced by extracorporeal shock wave lithotripsy: a clinical study.

Authors:  Binwu Sheng; Dalin He; Jun Zhao; Xingfa Chen; Xunyi Nan
Journal:  Urol Res       Date:  2010-07-06

3.  Shockwaves increase T-cell proliferation and IL-2 expression through ATP release, P2X7 receptors, and FAK activation.

Authors:  Tiecheng Yu; Wolfgang G Junger; Changji Yuan; An Jin; Yi Zhao; Xueqing Zheng; Yanjun Zeng; Jianguo Liu
Journal:  Am J Physiol Cell Physiol       Date:  2009-11-04       Impact factor: 4.249

4.  Preventive effects of COX-2 inhibitor, celecoxib on renal tubular injury induced by shock wave lithotriptor.

Authors:  Hyoung Keun Park; Hae Won Lee; Kwang Soo Lee; Jong Sun Choi; Byong Chang Jeong; Hyeon Hoe Kim
Journal:  Urol Res       Date:  2009-12-01

5.  Ways in which SWL affects oxidant/antioxidant balance.

Authors:  Erdal Yilmaz; Ahmet Haciislamoglu; Ucler Kisa; Ozlem Dogan; Ercan Yuvanc; Ertan Batislam
Journal:  Urolithiasis       Date:  2012-12-28       Impact factor: 3.436

6.  Variations in Nitric Oxide and Endothelin Serum Levels in Extracorporeal Shock Wave Lithotripsy-Treated Patients.

Authors:  Emir Milisic; Mustafa Hiros; Edin Begic
Journal:  Int J Appl Basic Med Res       Date:  2019 Apr-Jun

7.  By-products of lithotripsy: Are they related to abdominal fat and wave characteristics?

Authors:  Raed S M Al-Naemi; Haval Y Y Aldosky; Bayan S A Shukri
Journal:  J Taibah Univ Med Sci       Date:  2019-02-05

8.  Low-Intensity Shockwave Therapy (LI-ESWT) in Diabetic Kidney Disease: Results from an Open-Label Interventional Clinical Trial.

Authors:  Sune Moeller Skov-Jeppesen; Knud Bonnet Yderstraede; Boye L Jensen; Claus Bistrup; Milad Hanna; Lars Lund
Journal:  Int J Nephrol Renovasc Dis       Date:  2021-07-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.